Accuray

Accuray is a publicly traded medical device company with a mission to expand the curative power of radiation therapy through precision and innovation. Founded in 1990, it has achieved a significant global footprint with its CyberKnife and Radixact systems installed in over 100 countries. The company's strategy centers on technological differentiation in robotic and helical radiotherapy, supported by integrated software and services, to address a broad spectrum of cancer cases from complex to common. It aims to improve patient quality of life by making treatments shorter, safer, and more effective.

Two core hardware platforms: the CyberKnife robotic radiosurgery system for precise, frameless SRS/SBRT with real-time motion tracking, and the Radixact helical tomotherapy system for advanced image-guided IMRT and 3DCRT, supported by an integrated software ecosystem for planning, data management, and adaptive therapy.

Accuray is a niche competitor in a market dominated by giants Varian (Siemens Healthineers) and Elekta. Its competitive edge lies in the unique robotic architecture of CyberKnife for frameless radiosurgery and the helical delivery of Radixact, but it is challenged by the vast sales, service, and R&D resources of its larger rivals.